535 related articles for article (PubMed ID: 21872466)
1. Structure, mechanism, and inhibition of histone deacetylases and related metalloenzymes.
Lombardi PM; Cole KE; Dowling DP; Christianson DW
Curr Opin Struct Biol; 2011 Dec; 21(6):735-43. PubMed ID: 21872466
[TBL] [Abstract][Full Text] [Related]
2. Chemical Versatility in Catalysis and Inhibition of the Class IIb Histone Deacetylases.
Christianson DW
Acc Chem Res; 2024 Apr; 57(8):1135-1148. PubMed ID: 38530703
[TBL] [Abstract][Full Text] [Related]
3. Chemical and structural biology of protein lysine deacetylases.
Yoshida M; Kudo N; Kosono S; Ito A
Proc Jpn Acad Ser B Phys Biol Sci; 2017; 93(5):297-321. PubMed ID: 28496053
[TBL] [Abstract][Full Text] [Related]
4. Members of the histone deacetylase superfamily differ in substrate specificity towards small synthetic substrates.
Riester D; Wegener D; Hildmann C; Schwienhorst A
Biochem Biophys Res Commun; 2004 Nov; 324(3):1116-23. PubMed ID: 15485670
[TBL] [Abstract][Full Text] [Related]
5. On the function of the 14 A long internal cavity of histone deacetylase-like protein: implications for the design of histone deacetylase inhibitors.
Wang DF; Wiest O; Helquist P; Lan-Hargest HY; Wiech NL
J Med Chem; 2004 Jun; 47(13):3409-17. PubMed ID: 15189037
[TBL] [Abstract][Full Text] [Related]
6. Erasers of histone acetylation: the histone deacetylase enzymes.
Seto E; Yoshida M
Cold Spring Harb Perspect Biol; 2014 Apr; 6(4):a018713. PubMed ID: 24691964
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of a bacterial class 2 histone deacetylase homologue.
Nielsen TK; Hildmann C; Dickmanns A; Schwienhorst A; Ficner R
J Mol Biol; 2005 Nov; 354(1):107-20. PubMed ID: 16242151
[TBL] [Abstract][Full Text] [Related]
8. Structure of 'linkerless' hydroxamic acid inhibitor-HDAC8 complex confirms the formation of an isoform-specific subpocket.
Tabackman AA; Frankson R; Marsan ES; Perry K; Cole KE
J Struct Biol; 2016 Sep; 195(3):373-378. PubMed ID: 27374062
[TBL] [Abstract][Full Text] [Related]
9. An active site tyrosine residue is essential for amidohydrolase but not for esterase activity of a class 2 histone deacetylase-like bacterial enzyme.
Moreth K; Riester D; Hildmann C; Hempel R; Wegener D; Schober A; Schwienhorst A
Biochem J; 2007 Feb; 401(3):659-65. PubMed ID: 17037985
[TBL] [Abstract][Full Text] [Related]
10. Competitive or noncompetitive, that's the question: research toward histone deacetylase inhibitors.
Su H; Altucci L; You Q
Mol Cancer Ther; 2008 May; 7(5):1007-12. PubMed ID: 18483291
[TBL] [Abstract][Full Text] [Related]
11. Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors.
Finnin MS; Donigian JR; Cohen A; Richon VM; Rifkind RA; Marks PA; Breslow R; Pavletich NP
Nature; 1999 Sep; 401(6749):188-93. PubMed ID: 10490031
[TBL] [Abstract][Full Text] [Related]
12. Complex structure of a bacterial class 2 histone deacetylase homologue with a trifluoromethylketone inhibitor.
Nielsen TK; Hildmann C; Riester D; Wegener D; Schwienhorst A; Ficner R
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2007 Apr; 63(Pt 4):270-3. PubMed ID: 17401192
[TBL] [Abstract][Full Text] [Related]
13. Preparation of a new construct of human histone deacetylase 8 for the crystallization of enzyme-inhibitor complexes.
Porter NJ; Christianson DW
Methods Enzymol; 2019; 626():561-585. PubMed ID: 31606091
[TBL] [Abstract][Full Text] [Related]
14. How the flexibility of human histone deacetylases influences ligand binding: an overview.
Deschamps N; Simões-Pires CA; Carrupt PA; Nurisso A
Drug Discov Today; 2015 Jun; 20(6):736-42. PubMed ID: 25597521
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylases: structural determinants of inhibitor selectivity.
Micelli C; Rastelli G
Drug Discov Today; 2015 Jun; 20(6):718-35. PubMed ID: 25687212
[TBL] [Abstract][Full Text] [Related]
16. Chemistry of acetyl transfer by histone modifying enzymes: structure, mechanism and implications for effector design.
Hodawadekar SC; Marmorstein R
Oncogene; 2007 Aug; 26(37):5528-40. PubMed ID: 17694092
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, biological evaluation, and structural characterization of potent histone deacetylase inhibitors based on cyclic alpha/beta-tetrapeptide architectures.
Montero A; Beierle JM; Olsen CA; Ghadiri MR
J Am Chem Soc; 2009 Mar; 131(8):3033-41. PubMed ID: 19239270
[TBL] [Abstract][Full Text] [Related]
18. Structure-Based Inhibitor Discovery of Class I Histone Deacetylases (HDACs).
Luo Y; Li H
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33266366
[TBL] [Abstract][Full Text] [Related]
19. Isoform-selective histone deacetylase inhibitors.
Itoh Y; Suzuki T; Miyata N
Curr Pharm Des; 2008; 14(6):529-44. PubMed ID: 18336298
[TBL] [Abstract][Full Text] [Related]
20. Kinase and Histone Deacetylase Hybrid Inhibitors for Cancer Therapy.
Luan Y; Li J; Bernatchez JA; Li R
J Med Chem; 2019 Apr; 62(7):3171-3183. PubMed ID: 30418766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
